Category: Rx-360 Alerts

July 6, 2020 Update
As we move through the next two weeks Rx-360 wants to congratulate Jaye Greene ([email protected]), on her 1 year anniversary [...]
Read More
June 29, 2020 Update
As a reminder during the current travel restrictions and pandemic, Rx-360 has a vast library of final audit reports for [...]
Read More
June 22, 2020 Update
This week our Town Hall will be Wednesday June 24th at 12:00pm EST and will feature Marla Phillips, Ph.D., Director [...]
Read More
June 18, 2020 Update
Next week our Town Hall will be Wednesday June 24th at 12:00pm EST and will feature Marla Phillips, Ph.D., Director [...]
Read More
June 8, 2020 Update
This week our Town Hall will be Wednesday June 10th at 12:00pm EST and will feature Matthew Sample from AmerisourceBergen [...]
Read More
June 5, 2020 Update
Special thanks to our Town Hall panel this week who provided great insight of how pharmaceutical suppliers have adapted to [...]
Read More
June 1, 2020 Update
In today’s communication you will find new COVID-19 related updates as well as announcements for our next Town Hall Meeting. [...]
Read More
May 29, 2020 Update
In today’s communication you will find new COVID-19 related updates as well as announcements for our next Town Hall Meetings, [...]
Read More
May 27, 2020 Update
Please see below a few new COVID-19 related updates as well as announcements for our next Town Hall Meetings. Town [...]
Read More
May 26, 2020 Update
Over the course of this week you will be seeing multiple updates from Jim Fries on opportunities pertaining to virtual [...]
Read More
May 21, 2020 Update
Special thanks to Aaron Graham from Boehringer Ingelheim for being our guest yesterday on the Town Hall.  Counterfeiting continues to [...]
Read More
May 19, 2020 Update
Below you will find a number of Rx-360 Updates and Alerts in regard to COVID-19. FDA Updates: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-18-2020 FDA Related [...]
Read More
May 13, 2020 Update
Thank you for your continued hard work during the current pandemic and your interaction with Rx-360. Below you will find [...]
Read More
May 11, 2020 Update
Below you will find a number of Rx-360 Updates and Alerts in regard to COVID-19.  Please note that we are [...]
Read More
May 8, 2020 Update
Below you will find updates and alerts for May 8th, 2020.  We hope you continue to be safe and healthy. [...]
Read More
May 6, 2020 Update
Below you will find updates and alerts for May 6th, 2020.  I hope you continue to be safe and healthy. [...]
Read More
May 1, 2020 Update
Below you will find updates and alerts for May 1st, 2020. I hope you continue to be safe and healthy. [...]
Read More
April 28, 2020 Update
Below is the Rx-360 COVID-19 Update for today, Tuesday, April 28, 2020.  Don’t forget about our Town Hall this Thursday [...]
Read More
April 27, 2020 Update
Below is the Rx-360 COVID-19 Update for today, Monday, April 27, 2020.  Don’t forget about our Town Hall this week [...]
Read More
April 24, 2020 Update
Below is the Rx-360 COVID-19 Update for today, Friday, April 24, 2020. FDA Daily Update: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-23-2020 Falsified chloroquine found in Africa: https://www.securingindustry.com/pharmaceuticals/more-falsified-chloroquine-found-in-africa-says-who/s40/a11589/#.XqKnxPZFxBC [...]
Read More
April 23, 2020 Update
Please find below a reminder of our upcoming Town Hall Meetings on COVID-19 and other updates: Today, the Rx-360 Town [...]
Read More
April 22, 2020 Update
Below you will find update for today, Wednesday, April 22, 2020 regarding COVID-19 and Supply Chain Integrity. FDA Updates: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-21-2020 COVID-19 [...]
Read More
April 21, 2020 Update
Below you will find update for today, Tuesday, April 21, 2020 regarding COVID-19 and Supply Chain Integrity. FDA Updates: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-20-2020 Miami [...]
Read More
April 20, 2020 Update
Below you will find update for today, Monday, April 20, 2020 regarding COVID-19 and Supply Chain Integrity. Six Fraudulent Areas [...]
Read More
April 17, 2020 Update
Below you will find update for today, Friday, April 17, 2020 regarding COVID-19 and Supply Chain Integrity.   Today’s Update [...]
Read More
April 16, 2020 Update
Below you will find update for today, Thursday, April 16, 2020 regarding COVID-19 and Supply Chain Integrity.   As a [...]
Read More
April 15, 2020 Update
Below you will find update for today, Wednesday, April 15, 2020 regarding COVID-19 and Supply Chain Integrity. As a reminder, [...]
Read More
April 14, 2020 Update
Below you will find update for today, Tuesday, April 14, 2020 regarding COVID-19 and Supply Chain Integrity.   As a [...]
Read More
April 13, 2020 Update
Below you will find update for today, Monday, April 13, 2020 regarding COVID-19 and Supply Chain Integrity.   As a [...]
Read More
April 10, 2020 Update
Below you will find update for today, Friday, April 10, 2020 regarding COVID-19 and Supply Chain Integrity.  I hope everyone [...]
Read More
April 9, 2020 Update
Below you will find update for today, Thursday, April 9, 2020 regarding COVID-19 and Supply Chain Integrity.  I hope everyone [...]
Read More
April 8, 2020 Update
Below you will find update for today, Wednesday, April 8, 2020 regarding COVID-19 and Supply Chain Integrity.  Please note today’s [...]
Read More
April 7, 2020 Update
Below you will find update for today, Tuesday April 7, 2020 regarding COVID-19 and Supply Chain Integrity.  Please note this [...]
Read More
April 6, 2020 Update
Below you will find update for today, Monday April 6, 2020 regarding COVID-19 and Supply Chain Integrity.  Today’s update will [...]
Read More
April 3, 2020 Update
Below you will find our update for today, Friday April 3, 2020 regarding COVID-19 and Supply Chain Integrity.  Today’s update [...]
Read More
April 2, 2020 Update
Below you will find update for today, Thursday April 2, 2020 regarding COVID-19 and Supply Chain Integrity.  I hope that [...]
Read More
April 1, 2020 Update
Below you will find update for today, Wednesday April 1, 2020 regarding COVID-19 and Supply Chain Integrity.  I hope that [...]
Read More
March 31, 2020 Update
Below you will find update for today, Tuesday March 31, 2020 regarding COVID-19 and Supply Chain Integrity. REMINDER: Rx-360 ‘s [...]
Read More
March 30, 2020 Update
Below you will find update for today, Monday March 30, 2020 regarding COVID-19 and Supply Chain Integrity.  Rx-360 strives to [...]
Read More
March 27, 2020 Update
Today’s Rx-360 Update includes information from the FDA as well as information on shipping/logistics, and an announcement on our next [...]
Read More
March 26, 2020 Update
Below is the Rx-360 Update and Alert for today, March 26, 2020, on COVID-19 information that is relevant to current [...]
Read More
March 25, 2020 Update
Rx-360 hopes everyone is safe and healthy as we continue to work through challenges associated with the current global pandemic. [...]
Read More
March 24, 2020 Update
Below is the Rx-360 Update and Alert for today, March 24, 2020, on COVID-19 information that is relevant to current [...]
Read More
Town Hall Meeting with US Customs and Border Patrol Pharmaceutical Center of Excellence and Expertise
Rx-360 wants to personally invite you to a very special Town Hall Meeting that Rx-360 will be hosting as part [...]
Read More
Rx-360 COVID-19 Supply Chain Integrity and Patient Safety Alert
I hope everyone continues to be safe and healthy during this time. Today’s Rx-360 Update includes: Yesterday on March 18th, [...]
Read More
March 18, 2020 Update
In an effort, to provide resources to the Rx-360 Membership, during this time we will work hard to provide email [...]
Read More
FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)
Update [11/22/2019] FDA is alerting patients and health care professionals to two repackagers’ voluntary recalls of ranitidine. The medicines are being [...]
Read More
Torrent Pharma Warned by US Again, This Time for Using Bacteria-Contaminated Water System
Torrent Pharma warned by US again, this time for using bacteria-contaminated water system
Read More
Statement on New Testing Results, Including Low Levels of Impurities in Ranitidine Drugs
Americans deserve to have confidence in the quality of drugs the U.S. Food and Drug Administration regulates – from the [...]
Read More
FDA and DEA Warn Website Operators Illegally Selling Opioids – Drug Information Update
The U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration have issued joint warning letters to four online [...]
Read More
Counterfeit medication is endangering Arizonans. Here’s what you need to know.
Fake pills disguised as medication, such as painkillers and Xanax, are posing a deadly threat in Arizona, a group of law enforcement and [...]
Read More
Senate Bill Would Create a National Supply Chain Security Center
Citing the vital need for a secure U.S. industrial base, U.S. Senators Mike Crapo (R-Idaho) and Mark Warner (D-Virginia) have [...]
Read More
DEA’s National Take Back Day – April 27th 2019 @ 10:00am
The National Prescription Drug Take Back Day addresses a crucial public safety and public health issue. According to the 2017 National [...]
Read More
FDA: Safe Opioid Disposal – Remove the Risk Outreach Toolkit
Remove the Risk raises awareness of the serious dangers of keeping unused opioid pain medicines in the home and provides information [...]
Read More
Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan…
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due [...]
Read More
FDA Warns CanaRx for Selling Unapproved, Misbranded and Unsafe Imported Drugs to Unsuspecting Americans
The U.S. Food and Drug Administration posted a warning letter to CanaRx for facilitating the distribution of unapproved new drugs and [...]
Read More
Memorandum on Combating Trafficking in Counterfeit and Pirated Goods
Issued on: April 3, 2019 President Donald J. Trump issued a memorandum on Combating Trafficking in Counterfeit and Pirated Goods. [...]
Read More
Fraudulent Correspondence – Warning to all Members & Non-Members
Dear Rx-360 Members & Non-Members, Rx-360 has been made aware that fraudulent correspondence was sent to a small number of [...]
Read More
FDA Says Up to Two Million People Exposed to Likely Carcinogens in Blood-Pressure Drugs
As many as two million people world-wide have been exposed to a class of generic blood-pressure drugs containing probable human [...]
Read More
Revisoin 7 of ICH Q3C Guideline for Residual Solvents
In October 2018, the ICH Management committee issued Revisoin 7 of ICH Q3C Guideline for Residual Solvents.  The only change [...]
Read More
Five additional countries to benefit from EU-US mutual recognition agreement for inspections | European Medicines…
The US FDA has completed the capability assessment for an additional 5 EU regulators in November 2018: Estonia (State Agency [...]
Read More
Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP
Torrent Pharmaceuticals Limited is expanding its voluntary recall from 2 lots of Losartan potassium tablets USP to a total of 10 [...]
Read More
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality…
Ensuring the safety of our nation’s drug supply is a cornerstone of our consumer protection mission. Overseeing the quality and [...]
Read More
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications
The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou [...]
Read More
Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets
Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwide recall to [...]
Read More
Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable…
The FDA remains committed to ensuring that FDA-approved drugs are safe and effective for Americans. As part of this commitment, [...]
Read More
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide
Sandoz Inc. is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. This product [...]
Read More
5 Strategies To Combat Counterfeit Drugs And Other Pharma Supply Chain Threats
It’s hard enough to detect errors in the entire process of manufacturing and distributing one’s own pharmaceutical products, but pharma [...]
Read More
Mylan and Pfizer Report New Issues Affecting Some EpiPens That Can Delay Treatment
More than a month after Mylan and Pfizer reported to Health Canada that there are new issues affecting some EpiPens, [...]
Read More
FDA Gains New Powers to Block Illicit Drug Imports
A new US law that aims to tackle the national opioid crisis has been welcomed by FDA Commissioner Scott Gottlieb, [...]
Read More
FDA Updates on Valsartan Recalls
FDA releases method for detection and quantification of both NDMA and NDEA Update [10/11/2018] ] FDA is posting a redeveloped combined [...]
Read More
The Uphill Fight Against Fake Prescription Drugs
Tosh Ackerman took part of what he thought was a Xanax pill to help him sleep one night three years [...]
Read More
MHRA Says Falsified Medicines Directive Could Cost £500m Over Ten Years
The Medicines and Healthcare products Regulatory Agency (MHRA) has estimated that implementing the Falsified Medicines Directive (FMD) in the UK [...]
Read More
Pfizer, Inc. Issues A Voluntary Nationwide Recall Of One Lot Of Children’s Advil® Suspension Bubble…
Pfizer Consumer Healthcare, a division of Pfizer Inc., is voluntarily recalling one lot of Children’s Advil® Suspension Bubble Gum Flavored 4 [...]
Read More
Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center…
Millions of Americans take medication daily to control their blood pressure. We recently found that some generic versions of one [...]
Read More
FDA Announces Voluntary Recall of Montelukast Tablets by Camber Pharmaceuticals Due to Incorrect Drug in…
The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot [...]
Read More
Product Quest Manufacturing LLC Recalls All Nasal Products and Baby Oral Gels Manufactured at Florida…
Product Quest Manufacturing (“Product Quest”) announced its voluntary recall of Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal [...]
Read More
URI Chemistry Professor Develops New Contaminant Detection Technique for Blood Thinner Heparin
In 2008, a contaminant eluded the quality safeguards in the pharmaceutical industry and infiltrated a large portion of the supply [...]
Read More
Over Half Of U.S. States Have Now Seen Fatalities From Counterfeit Drugs Made With Fentanyl
During a roundtable discussion focused on the nation’s worsening opioid crisis, advocates for ensuring a safe drug supply shared new [...]
Read More
FDA Alerts Drug Makers of a Recall of Porcine Thyroid API from Sichuan Friendly Pharmaceutical…
FDA is alerting active pharmaceutical ingredient (API) repackagers and distributors, finished drug manufacturers, and compounders that Sichuan Friendly Pharmaceutical Co. Limited, [...]
Read More
Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling 14 lots of Valsartan/Amlodipine/HCTZ tablets to the consumer level due to the detection of [...]
Read More
Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due…
Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 [...]
Read More
Chinese Vaccine Maker Made 500,000 Substandard Baby Vaccines: Xinhua
A Chinese drug company produced nearly 500,000 substandard vaccines for babies, roughly double an earlier estimate by authorities investigating a [...]
Read More
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets
As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg [...]
Read More
Proposed Changes To WHOIS System Privacy Will Help Hide Internet Criminals, NABP Director Warns
Every week brings new details of the negative externalities of social media and e-commerce websites. But fake bots aren’t the [...]
Read More
EMA Reviewing Medicines Containing Valsartan from Zhejiang Huahai Following Detection of an Impurity
The European Medicines Agency (EMA) is reviewing medicines containing the active substance valsartan that is supplied by Zhejiang Huahai Pharmaceuticals, a company [...]
Read More
EU Sees One in 5,000 Cancer Risk from Tainted China Heart Drug
The European Medicines Agency estimates there could be one extra case of cancer for every 5,000 patients taking a common [...]
Read More
China Heart Drug Sold Globally May Have Had Impurity Since 2012
The revelation that the problem likely dates back to changes in manufacturing processes at Zhejiang Huahai Pharmaceutical six years ago [...]
Read More
FDA Updates on Valsartan Recalls
Update [8/2/2018] FDA continues to evaluate valsartan-containing products and has updated the list of products included in the recall and the list of products not included [...]
Read More